Scientists described a medium-throughput, unbiased small molecule screen to identify novel disease mechanisms and therapeutic targets using induced pluripotent stem cell (iPSC) technology.
[Stem Cell Reports]
A Phenotypic Screen of Marfan Syndrome iPSC-Derived Vascular Smooth Muscle Cells Uncovers GSK3β as a New Target
